Composite Government Tracker Insider Trading Hedge Funds Red Flags Financials

Financials

MRNA

Moderna, Inc. · Biological Products, (No Diagnostic Substances)

Financials Score

★★★★★

Metrics Available10 / 10

You vs. Peer Average

Gross Margin

MRNA

55.4%

Peers

67.2%

Operating Margin

MRNA

-158.1%

Peers

26.7%

Net Margin

MRNA

-145.2%

Peers

18.9%

Revenue Growth (YoY)

MRNA

-39.9%

Peers

2.4%

Earnings Growth (YoY)

MRNA

20.8%

Peers

40.2%

Return on Equity

MRNA

-32.6%

Peers

3.5%

Return on Assets

MRNA

-22.9%

Peers

4.4%

Debt / Equity

MRNA

0.07x

Peers

0.72x

Current Ratio

MRNA

3.29x

Peers

3.69x

FCF Margin

MRNA

-106.2%

Peers

24.1%